European Immunology 2025| June 23-24, 2025 | Paris

Autoimmune diseases, Vaccine development , Monoclonal antibodies, Cytokine storm, T-cell therapy , Immune checkpoint inhibitors , Immuno-oncology , Immunomodulation , Innate vs. adaptive immunity , Immune system, Antibody, Haematopoiesis, Plasma cells ,Vaccination, Antigen, Immunotherapy, Immunotherapy, Pathogen, Immunoglobulin,Immunodeficiency.

Renowned Speakers

Yongqun Oliver

University of Michigan Medical School USA

Roswitha Gropp

Hospital of the LMU Germany

Kathleen Schwarz

Johns Hopkins University School of Medicine USA

Dina Antunes

Oswaldo Cruz Foundation Brazil

Eva M Carmona

Mayo Clinic College of Medicine USA

Yutong Zhao

University of Pittsburgh USA

Michael Vajdy

University of Connecticut USA

Gilbert Glady

European Bio Immun(G)en Medicine Association France

Recommended Global Immunology Webinars & Conferences

Europe & UK

Stress Meet 2025, France WOMEN HEALTH CONFERENCE 2025, France

Asia Pacific & Middle East

Health Care-2025, Singapore Neurologists Meeting 2024, UAE Stress 2025, Thailand WOMENS HEALTH MEET 2025, Indonesia

Canada

Antibiotics Resistance 2024, Canada Womens Health 2025, Canada IMMUNOLOGY CONGRESS 2025, Canada

European Immunology 2025

About conference

It's our privilege to invite all the Researchers, Scientists and Experts on behalf of committee members to be the part of the prestigious 19^thInternational conference on European Immunology schedule on June 23-24, 2025 at paris, France . We aim to unify all the people indulged in this vast field and share the knowledge, explore and look forward to the new way by integrating new thoughts and customizing the limits of future technology.

European Immunology 2025 offers an attention to explore, grip and meet with prominent speakers of the field, including both broad and specific subjects. The European Immunology 2025 will be surrounding around the theme “Exploring the dynamic interplay of pathogens and the immune system”.

The European Immunology 2025 is designed with the Keynote sessions, Session lectures and Poster presentations, Young Researchers, Panel Discussions and the B2B meetings with world-renowned speakers from the stream of immunology. It provides the best platform for the researchers all over the globe to introduce themselves to the innovative world with their unique research.

WHY TO ATTEND?

European Immunology 2025 is aimed the World's leading Medical Conference. The two days event on Immunology & Immunogenetics will host 60+ Scientific and technical sessions and sub-sessions on leading and latest research transformation related to the field, covering the globe. European Immunology 2025 will comprise of 50 major sessions designed to offer comprehensive sessions that discourse current topics in the field.

The attendees can find exclusive sessions and panel discussions on the latest innovations in Molecular Immunology & Immunogenetics by:

Lectures from renowned speakers
Keynote forums by Prominent Professors, Engineers
Open Innovation Challenges
Poster presentations by Young Researchers
Global Networking sessions with 50+ Countries
Novel techniques to benefit your research
Best platform for Global business and Networking opportunities
Meet the editors of refereed journals, Society and Association members across the Globe
Excellent platform to showcase the latest innovation and concept in the technical field

Target Audience:

Immunologists
Rheumatologists
Microbiologists
Pulmonologists
Allergists
Pathologists
Clinical Immunologists
Physicians
Pediatricians
Virologists
Biotechnologists
Immunology professionals
Infectious diseases treatment doctors
University Professors
Various Societies and their members
Institutes-Medical Schools Students
Research Scholars
Laboratory technicians
Business Entrepreneurs
Manufacturing Medical Devices Companies
Companies producing vaccines, GMO’s and allergy therapeutics

Scope & Importance:

European Immunology 2025 will involve significant sessions intended to offer comprehensive sessions that address current issues in Immunology, Allergy, and relevant Biomedical Sciences. The participants can discover Exclusive Sessions and Panel discourses on most recent advancements in Immunology and Biomedical Sciences, Lectures by the dynamic Investigators, Keynote gatherings by Renowned Immunologists, speaker forums, Poster Sessions on most recent Innovation in all the pertinent Areas, Open Innovation Challenges, Poster Sessions on each vocation organize, Young Research Forum, Post-Doctoral Career Development Session, B2B Meetings, Global Networking with 50+ Countries, Novel strategies to profit your exploration, Best stage for Global business and Networking openings, Meet the editors of refereed journals, Society and Association individuals over the Globe, Excellent stage to exhibit the most recent items in Immunology and subsidiaries.

Sessions/Tracks

Track 1: Immunology

Immunology is a field that investigates the structure, function, and interactions of the immune system components, including immune cells (T cells, B cells, and macrophages), cytokines, and antibodies. It explores how the immune system distinguishes between self and non-self-antigens, initiate’s immune responses against pathogens, and maintains tolerance to prevent autoimmune diseases. Research in immunology spans molecular mechanisms of antigen recognition, immune cell activation pathways, and immune memory formation. Practical applications include developing vaccines, immunotherapies for cancer and autoimmune disorders, and diagnostics for infectious diseases.

Related Societies and Associations:

USA:

American Association of Immunologists (AAI),Clinical Immunology Society (CIS),Society for Immunotherapy of Cancer (SITC),American College of Allergy, Asthma & Immunology (ACAAI),American Society for Histocompatibility and Immunogenetics (ASHI),Association of Medical Laboratory Immunologists (AMLI),American Society for Microbiology (ASM),Federation of Clinical Immunology Societies (FOCIS),American Autoimmune Related Diseases Association (AARDA),Clinical Immunology Society (CIS),American Academy of Allergy, Asthma & Immunology (AAAAI),American College of Rheumatology (ACR),American Society of Transplantation (AST)

Europe:

European Federation of Immunological Societies (EFIS),British Society for Immunology (BSI),German Society for Immunology (DGfI),French Society of Immunology (SFI),Italian Society of Immunology, Clinical Immunology, and Allergology (SIICA),Dutch Society for Immunology (NVVI),Spanish Society for Immunology (SEI),Swiss Society for Allergology and Immunology (SSAI),Austrian Society for Allergology and Immunology (ÖGAI),Scandinavian Society for Immunology (SSI),Belgian Immunological Society (BIS),Hungarian Society for Immunology (HSI),Polish Society of Experimental and Clinical Immunology (PSECI),Portuguese Society of Immunology (SPI),Russian Society of Immunologists (RSI)

Asia-Pacific:

Australasian Society for Immunology (ASI),Japanese Society for Immunology (JSI),Korean Association of Immunologists (KAI),Chinese Society of Immunology (CSI),Indian Immunology Society (IIS):,Hong Kong Society for Immunology (HKSI),Taiwan Immunology Society (TIS),Singaporean Society for Immunology (SgSI),Malaysian Society of Allergy and Immunology (MSAI),Thai Society of Immunology (TSI),Philippine Society of Allergy, Asthma, and Immunology (PSAAI),Indonesian Society for Allergy and Immunology (ISAI),New Zealand Society for Immunology (NZSI),Pakistan Society for Immunology (PSI),Sri Lanka College of Allergy, Asthma and Clinical Immunology (SLCAAI)

Track 2: Immune System

The immune system is a complex network of organs, tissues, and cells that work together to defend the body against infections and diseases. It comprises innate immunity, which provides immediate defence through barriers and cells like neutrophils and macrophages, and adaptive immunity, which involves T and B lymphocytes that provide specific responses and memory against pathogens. Key organs include lymph nodes, spleen, thymus, and bone marrow, which support immune cell development, maturation, and coordination. The immune system's ability to recognize and respond to foreign antigens while maintaining tolerance to self is crucial for health and disease prevention.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 3: Cancer Immunology and Immunotherapy
Cancer immunology explores how tumours evade immune surveillance and manipulate the immune microenvironment to promote growth and survival. It investigates immune checkpoint pathways (e.g., PD-1/PD-L1) that inhibit anti-tumour immune responses and immunosuppressive mechanisms within the tumour microenvironment. Immunotherapy strategies aim to activate and enhance the body's immune responses against cancer, including checkpoint inhibitors, adoptive cell therapies like CAR-T cells, cytokine therapies, and therapeutic vaccines. These approaches harness the immune system's potential to recognize and eliminate cancer cells, offering new treatment options and improving outcomes for cancer patients.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 4: Immunotoxicology

Immunotoxicology studies how exposure to chemicals, drugs, or environmental pollutants affects immune function and increases susceptibility to diseases. It examines adverse effects such as immunosuppression, hypersensitivity reactions, autoimmune disorders, and chronic inflammation caused by environmental toxins or pharmaceuticals. Research in Immunotoxicology involves evaluating immune cell function, cytokine production, and immune system integrity using experimental models and biomarkers. This field plays a crucial role in assessing the safety of drugs, chemicals, and consumer products, guiding regulatory decisions, and protecting public health from immune-related risks.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 5: Neuroimmunology

Neuroimmunology investigates interactions between the immune system and the central nervous system (CNS), exploring how immune responses influence neurological diseases and disorders. It examines immune cell infiltration into the CNS, neuroinflammatory pathways, and immune-mediated mechanisms contributing to diseases such as multiple sclerosis, Alzheimer's disease, and stroke. Research in neuroimmunology aims to understand how immune responses affect neural function, synaptic plasticity, and neurodegenerative processes. Therapeutic strategies focus on modulating neuroinflammation, promoting neuroprotection, and restoring neurological function through targeted immunomodulatory approaches and interventions.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 6: Immunodeficiency

Immunodeficiency disorders impair the immune system's ability to defend against infections and diseases, resulting from genetic defects (primary immunodeficiencies) or acquired conditions (secondary immunodeficiencies). Primary immunodeficiencies affect immune cell development, function, or signaling pathways, leading to recurrent infections, opportunistic infections, and increased susceptibility to autoimmune diseases or cancers. Secondary immunodeficiencies can arise from infections, medications (e.g., chemotherapy), malnutrition, or aging, compromising immune responses and overall health. Management includes immunoglobulin replacement therapy, antimicrobial prophylaxis, and stem cell transplantation to restore immune function and improve quality of life for patients with immunodeficiency disorders.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track7: Epidemiology

Epidemiology is the study of disease patterns, determinants, and distribution within populations to inform public health policies and interventions. It employs rigorous methods to investigate disease outbreaks, risk factors, and health disparities across diverse populations. Epidemiological research encompasses study designs such as cohort studies, case-control studies, and meta-analyses to generate evidence for disease prevention, health promotion, and healthcare planning. Applications include identifying disease trends, assessing the impact of interventions, developing vaccination strategies, and implementing screening programs to reduce disease burden and improve population health outcomes.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 8: Transplantation Immunology

Transplantation immunology examines immune responses to transplanted organs, tissues, or cells, focusing on understanding rejection mechanisms and promoting graft acceptance. It investigates histocompatibility (HLA) matching between donor and recipient to minimize immune recognition and rejection. Research in transplantation immunology explores immunosuppressive therapies, tolerance induction strategies, and biomarkers to predict graft outcomes and improve long-term transplant success rates. Advances in transplantation immunology have expanded donor options, enhanced transplant outcomes, and improved quality of life for recipients of solid organ, tissue, and hematopoietic stem cell transplants.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 9: Immunotherapy

Immunotherapy represents a transformative approach in treating diseases by leveraging the body's immune system to target and eliminate abnormal cells, such as cancer cells or those involved in autoimmune disorders. It encompasses various strategies, including immune checkpoint inhibitors (e.g., PD-1/PD-L1 blockers), which unleash the immune system's ability to recognize and destroy cancer cells; adoptive cell therapies like CAR-T cells, where patient's T cells are engineered to target specific cancer antigens; and cytokine therapies that enhance immune responses. Immunotherapy has revolutionized cancer treatment, offering durable responses, fewer side effects compared to traditional therapies like chemotherapy, and potential applications in treating autoimmune diseases and infectious diseases.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 10: Immunoinformatics & Systems Immunology

Immunoinformatics integrates computational and systems biology approaches to analyze complex immunological data. It uses bioinformatics tools and algorithms to study immune system components, predict interactions between antigens and antibodies, and identify potential vaccine candidates. Systems immunology explores immune system dynamics at a holistic level, integrating high-throughput data to understand immune cell networks, signaling pathways, and regulatory mechanisms. These approaches facilitate personalized medicine by elucidating immune responses in health and disease, accelerating vaccine development, and informing strategies for immunotherapy and precision medicine interventions.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 11: Immunological Techniques

Immunological techniques encompass a diverse array of laboratory methods used to study immune system components, functions, and responses. These include flow cytometry for analyzing immune cell populations and phenotypes, ELISA and multiplex assays for quantifying cytokines and antibodies, Western blotting and proteomics for protein expression analysis, and PCR and next-generation sequencing for gene expression profiling and immune repertoire analysis. Advanced techniques like mass spectrometry enable detailed characterization of immune molecules and their interactions. Immunological techniques are essential for basic research, clinical diagnostics, vaccine development, and monitoring immune responses in various diseases and therapies.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 12: Immunogenetics

Immunogenetics investigates the genetic basis of immune responses, focusing on genes that encode molecules involved in immune recognition, activation, and regulation. Key areas include human leukocyte antigen (HLA) genes, which determine compatibility in organ transplantation and influence susceptibility to autoimmune diseases and infectious diseases. Immunogenetic studies also explore polymorphisms and gene variations associated with immune response variability among individuals, including responses to vaccines and immunotherapies. Understanding immunogenetics helps personalize medicine by predicting disease risks, optimizing treatment strategies, and developing targeted therapies based on individual genetic profiles.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 13: Pediatrics Immunology

Pediatric immunology specializes in understanding immune system development, function, and disorders in children. It explores neonatal immune responses, immune maturation during childhood, and immune system interactions with infections, vaccines, and environmental factors. Pediatric immunologists diagnose and manage immune-related conditions specific to pediatric populations, such as primary immunodeficiencies, allergies, autoimmune diseases, and immunization strategies. Research in pediatric immunology focuses on optimizing vaccine schedules, enhancing immune responses in young patients, and developing safe and effective treatments tailored to pediatric immune systems.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 14: Diagnostic and Technological Novelty of Immunology

The diagnostic and technological innovations in immunology encompass cutting-edge methods and technologies that advance disease detection, monitoring, and treatment. These include high-throughput sequencing for immune repertoire analysis, single-cell technologies for studying immune cell heterogeneity, multiplex assays for biomarker detection, and advanced imaging techniques for visualizing immune responses in tissues. Novel diagnostic tools like biosensors and microfluidics platforms enable rapid and sensitive detection of immune biomarkers, pathogens, and immune cell interactions. Technological advancements in immunology drive precision medicine initiatives, improve patient outcomes, and accelerate research in immunological disorders and therapies

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 15: Viral Immunology

Viral immunology focuses on understanding immune responses against viral infections, including mechanisms of viral entry, replication, and evasion of host immune defences. It explores innate immune responses (e.g., interferon signalling, natural killer cell activation) and adaptive immune responses (e.g., T and B cell-mediated immunity, antibody production) crucial for controlling viral pathogens. Research in viral immunology informs vaccine development, antiviral therapies, and strategies to combat emerging viral diseases and pandemics. Understanding viral-host interactions and immune evasion mechanisms is essential for developing effective vaccines, antiviral treatments, and public health interventions against viral infections.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 16: Parasite Immunology

Parasite immunology investigates immune responses to parasitic infections caused by protozoa, helmets, and other parasites. It explores host immune mechanisms involved in recognizing, responding to, and eliminating parasites, as well as parasite strategies for immune evasion and survival within the host. Research in parasite immunology aims to identify parasite-specific antigens, understand immune modulatory effects of parasites on host immunity, and develops vaccines and treatments against parasitic diseases. Insights into parasite-host interactions and immune responses contribute to strategies for disease prevention, control, and management in endemic regions.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Track 17: Reproductive Immunology

Reproductive immunology examines immune responses related to pregnancy, fertility, and reproductive disorders. It investigates immune tolerance mechanisms that enable successful embryo implantation, fetal development, and pregnancy maintenance while preventing maternal immune rejection of the fetus. Research in reproductive immunology addresses immunological factors contributing to infertility, recurrent miscarriages, pregnancy complications such as preeclampsia, and preterm birth. Insights into immune interactions at the maternal-fetal interface guide therapeutic interventions to support reproductive health, improve pregnancy outcomes, and develop immune modulatory strategies for reproductive disorders.

Related Societies and Associations:

USA:

Europe:

Asia-Pacific:

Market Analysis

The global immunology market size was valued at USD 77,365.4 Million in 2018 and is projected to reach USD 143,833.2 Million by 2026, exhibiting a CAGR of 8.1% in the forecast period.

Existing market players operating in the global immunology market are focusing on constant innovations and up-gradation of their product portfolio with new and efficient product offerings for better treatment outcomes for the patients. One of the primary reasons for the growth of the global market is the increasing incidence of immunological and autoimmune diseases. Rise in awareness regarding immunological diseases in both developing and developed nations, and the higher prevalence of immunological disorders due to environmental factors, thus propelling the of the global immunology market growth. This coupled with, increasing investments by major players in research and development activities are also boosting the growth of the market globally.

The change in the immunology market share is also primarily driven by a greater focus towards the R&D initiatives due to recent regulatory approvals, increasing trends of patent expiry and the subsequent emergence of comparatively cheaper biosimilars. Some of the other factors which are also contributing to the growth of the market are the increase in the efficiency of the immunology drugs leading to better patient outcomes and improved quality of life. The introduction of new and sophisticated targeted therapies such as TREMFYA by Janssen Global Services, LLC (Johnson & Johnson) and Cosentyx by Novartis AG is expected to drive the growth of the immunology market in developed as well as emerging countries, during the forecast period 2019-2026.

"Increasing adoption of monoclonal antibody (mAb), combined with the increasing prevalence of immunological diseases is driving the growth of the global market". Increasing adoption and demand for monoclonal antibody (mAb), which is the drug class of a number of immunology drugs and have a number of associated advantages such as its status as a high specific therapy, is one of the most prominent driving factors for the growth of the global immunology industry in 2018. Increasing R&D initiatives in the monoclonal antibody segment and a large number of drugs under the segment is also driving the growth in the monoclonal antibody (mAb) segment.

The immunosuppressant segment is estimated to grow at a faster CAGR during the forecast period. This is attributed to the anticipated increase in the revenue under this drug class, with the interleukin inhibitors becoming more prominent in the immunology market trend. Currently, there is increasing adoption of the immunosuppressant in the markets in the developing nations due to its higher achievement in terms of the efficient treatment leading to improved patient outcomes, and this is expected to contribute to the growth of the market at higher CAGRs during the forecast period.

Regional Analysis

"Growing Prevalence and Awareness of Autoimmune and Immunological Disorders and Increasing Adoption of Immunology Drugs Expected to Result in the Highest CAGR in the Asia Pacific".

North America generated revenue of US $41,622.5 Million in 2018 and is anticipated to account for a dominant share in the global market during the forecast period. The immunology market growth witnessed in the region is likely to be driven by the increasing adoption of advanced immunology drugs and rising prevalence of autoimmune and immunological disorders.

This is especially applicable in instances where there is a steady escalation of the symptoms and the disease progresses due to lack of efficient treatment. In developed countries, the adoption of advanced immunology drugs such as immunosuppressant is increasing along with the existing drug classes of monoclonal antibody (mAb) and polyclonal antibody (pAb) amongst others.

Past Conference Report

European Immunology 2024

The 18^th International Conference on European Immunology hosted by Conference Series LLC was successfully held during May 23-24, 2024 at Zurich, Switzerland and was marked with the presence of the committee members, senior scientists, young and brilliant researchers, business delegates and talented students from various countries, who made this conference successful and productive.

This conference highlighted the theme “Scrutinizing Progressions in the field of Immunology” with the following scientific tracks:

Immunology
Immune System
Cancer Immunology and Immunotherapy
Immunotoxicology
Neuroimmunology
Immunodeficiency
Epidemiology
Transplantation Immunology
Immunotherapy
Immunoinformatics & Systems immunology
Immunological techniques
Immunogenetics
Pediatrics Immunology
Diagnostic and Technological novelty of Immunology

Conference Series LLC has taken the privilege of felicitating European Immunology 2024 Organizing Committee, and Keynote Speakers who supported the event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand European Immunology 2024 Conference.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance. With the unique feedback from the conference, Conference Series LLC Ltd would like to announce the commencement of the 19^th International Conference on European Immunology. We cordially welcome all the eminent Researchers, Scientists, Professors, and Nurses to be part of this prestigious conference.

Bookmark your dates for European Immunology 2025 as the Nominations for Best Poster Awards and Young Researcher Awards are open across the world.

Accreditation

All major Conference Series Conferences are accredited with Continuing Education (CE), Continuing Professional Development (CPD) and Continuing Medical Education (CME) credits respectively.

CME Credits:

Continuing Medical Education (CME) refers to a specific form of continuing education that helps medical professionals to maintain competence and learn about new and developing areas of their field. Conference Series Conferences are recognised and accredited with CME credits to enhance the professional abilities and skills of participants. CME credits are important to physicians because they require a specified number of credits annually to maintain medical licenses. CME credits are authorized by the Accreditation Council for Continuing Medical Education. Attending CME accredited conference is beneficial and valuable to physicians and other medical professional as it is a source of constant improvement that ultimately improves their medical practice, and keeps them up-to-date on the latest technologies, advancements, treatments, etc. Speaking at CME activities can also be a great stage for clinical medical professionals to share their expertise and increase their distinction in their specialty.

CE Credits:

Continuing Education (CE) credit is a measure used in continuing education programs to assist the professional to maintain his or her license in their profession. Conference Series Conferences provides ample opportunities to acquire CE credits. CE can open up previously closed doors and lead to better job opportunities. CE usually refers to college courses or other vocational training obtained by older adults or working professionals. CE credits work as carrier promoter and hold great value in medical, clinical and other areas of research even after completion of degrees in concerned field of research. It is pivotal in today’s world to get updated information on your field of research and profession. Attending Continuing Education Conferences can help expand your network and make connections that could translate into profitable relationships or job opportunities down the line. It also plays a vital role in recruiting new team members for an employer with open positions. CE helps licensing organizations and professional membership groups. Continuing Education promotes high quality performance, keep professionals up to date with the latest advances, and provide excellent networking opportunities.

CPD Credits:

Continuing Professional Development (CPD) is the holistic commitment of professionals towards the enhancement of personal skills and proficiency throughout their careers. It enables learning to become conscious and proactive, rather than passive and reactive. CPD accreditation is important because it ensures that courses provided adhere to the highest educational standards and international benchmarks of quality and learning. CPD enriches your knowledge, keeps you currently competent and is the key to career progression and professional growth. There are many advantages to carrying out CPD that includes filling gaps in your knowledge and skills to become more productive and efficient, building confidence and credibility to stand out from the crowd, achieving your career goals and demonstrating professional status. CPD hours can be earned through continuing education, leadership activities, instructional activities, completion of significant work projects, research and publications. Conference Series Conferences have been accredited with CPD credits to expedite the progress of research and industry professionals.